NCT04220671View on ClinicalTrials.gov

Measles Vaccination at Health System Contacts

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

5,400

Participants

Timeline

Start Date

January 8, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Measles VaccineHospital AdmissionMortalityNon-specific (Heterologous) Effects of Vaccines
Interventions
BIOLOGICAL

measles vaccine

Measles vaccine, Edmonston-Zagreb strain, 0.5 ml administered as a subcutaneous injection

OTHER

Saline

0.9% NaCl

Trial Locations (1)

Unknown

Bandim Health Project, Bissau

All Listed Sponsors
lead

Bandim Health Project

OTHER